Patent details

EP3199165 Title: METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA

Basic Information

Publication number:
EP3199165
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171608219
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA
French Title of Invention:
PROCÉDÉS ET COMPOSITIONS POUR L'INHIBITION SPÉCIFIQUE DE KRAS PAR DE L'ARN DOUBLE BRIN ASYMÉTRIQUE
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN FÜR SPEZIFISCHE KRAS-HEMMUNG MIT ASYMMETRISCHER DOPPELSTRANG-RNA
SPC Number:

Dates

Filing date:
05/04/2010
Grant date:
08/06/2022
EP Publication Date:
02/08/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/06/2022
EP B1 Publication Date:
08/06/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/04/2023
Expiration date:
05/04/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/06/2022
 
 

Name:
Dicerna Pharmaceuticals, Inc.
Address:
75 Hayden Avenue, Lexington, Massachusetts 02421, United States (US)

Inventor

Name:
Brown, Bob Dale
Address:
United States (US)

Priority

1

Priority Number:
166559 P
Priority Date:
03/04/2009
Priority Country:
United States (US)

2

Priority Number:
166578 P
Priority Date:
03/04/2009
Priority Country:
United States (US)

3

Priority Number:
174306 P
Priority Date:
30/04/2009
Priority Country:
United States (US)

4

Priority Number:
174279 P
Priority Date:
30/04/2009
Priority Country:
United States (US)

5

Priority Number:
183815 P
Priority Date:
03/06/2009
Priority Country:
United States (US)

6

Priority Number:
183818 P
Priority Date:
03/06/2009
Priority Country:
United States (US)

7

Priority Number:
184735 P
Priority Date:
05/06/2009
Priority Country:
United States (US)

8

Priority Number:
PCT/US2009/005214
Priority Date:
17/09/2009
Priority Country:
World Intellectual Property Office (WIPO) (WO)

9

Priority Number:
257810 P
Priority Date:
03/11/2009
Priority Country:
United States (US)

10

Priority Number:
257820 P
Priority Date:
03/11/2009
Priority Country:
United States (US)

11

Priority Number:
285925 P
Priority Date:
11/12/2009
Priority Country:
United States (US)

12

Priority Number:
642404
Priority Date:
18/12/2009
Priority Country:
United States (US)

13

Priority Number:
642371
Priority Date:
18/12/2009
Priority Country:
United States (US)

14

Priority Number:
642264
Priority Date:
18/12/2009
Priority Country:
United States (US)

15

Priority Number:
704256
Priority Date:
11/02/2010
Priority Country:
United States (US)

16

Priority Number:
309266 P
Priority Date:
01/03/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/713; C12N 15/113;

Publication

European Patent Bulletin

Issue number:
202223
Publication date:
08/06/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages